 Home > Medical News >

Medical Research Articles

Methafluoluothantinib listing application approved for treatment of chronic adult patients with chronic myeloid leukemia

 Time of Update: 2020-06-07

bubble drug abilify drug pink new drug xarelto drug class mde drug

recently, it was reported that the listing application for methionate flumartinibinib (product name: Haussen-Fu) was approved for the treatment of chronic myeloid leukemia (Ph-CML) chronic adult pat
Gilead announces new clinical research data on hepatitis B functional cure new drug GS-9688

 Time of Update: 2020-06-07

antigen receptor benzodiazepine receptor agonist hbsag treatment small data gs pool

recently, Gilead, the giant of pharmaceutical (http:// released new clinical research data on the functional cure the new drug (http:// Gs-9688( selgantolimod) About GS-9688 GS-9688 is an or
Key Phase 2 trial of DS-8201, co-developed by AstraZeneca and Phase III, reaches the main research end

 Time of Update: 2020-06-07

monoclonal antibodies examples phase contrast ds 82 plasma phase iridite 14 2

today, AstraZeneca and Daiichi Sankyo company (http:// announced that the joint development of antibody conjugate drug (http:// (aDC) (fam-8201), in the treatment of HER2-positive metastatic b
Novo Nordisk Valley Gate Winter Double Insulin Injection (Novo and Jia ®) officially launched in China

 Time of Update: 2020-06-07

injection vial double stranded rna cefepime injection aranesp injection fasting lower blood sugar

recently, Novo Nordisk announced that the world's first soluble double insulin degudurd double insulin injection (Novo and Jia ®) has been officially launched in China to treat type 2 diabetes in ad
Scientists develop a new drug candidate for breast cancer

 Time of Update: 2020-06-07

stem cells used vitamin b9 supplements anti vitamin anti inflammatory breast cancer pill

recently, scientists have discovered a new drug (http:// that could starve or suffocate cancer stem cells, paving the way for new treatments for breast cancer patients The study at the Universi
The phase 3 trial of Takeda protease inhibitor Ninlaro (ixazomib) reaches the main end of the trial

 Time of Update: 2020-06-07

medical ketamine clinical trials antipsychotic drugs used treat protease phentermine fda approved

today, Takeda (http:// announced that its protease inhibitor Ninlaro (ixazomib) as a first-line maintenance therapy, in the treatment of adult patients with multiple myeloma (MM) without stem cel
NMPA approves Theiboantium drug Fycompa for treatment of seizures at age 12 and over

 Time of Update: 2020-06-07

viibryd drug new china covington photosensitive drug reaction librium drug savella drug

Recently, Eisai, a Japanese pharmaceutical company, announced that China's National Drug (http:// Regulatory Authority (NMPA) has approved a new generation of anti-epileptic drug Fycompa (perampa
Three companies jointly conduct clinical trials of antibody-linked drug enfortumab vedotin and Keytruda to treat urinary skin cancer

 Time of Update: 2020-06-07

anti parietal cell antibodies anti srp antibody phase 1 metabolism anti cancer living fuel cell companies

Recently, Seattle Genetics and Astellas announced a partnership agreement with Mercadon to jointly conduct a clinical trial (http:// for the treatment of pre-local advanced or metastatic urinary
Weishi's new drug, ® (FYCOMPA®), has been approved by China's State Drug Administration

 Time of Update: 2020-06-07

eddp drug azo drug topiramate drug class drug test preparation clonazepam drug

recently, the State Medicines (http:// Administration of China has approved the use of the Weishi New Drug (http:// The ® (FYCOMPA®) for the use of adults and children 12 years and older with
And platinum medicine next-generation all-human anti-CTLA-4 antibody HBM4003 first patient has been successfully enrolled in the group medication

 Time of Update: 2020-06-07

platinum compounds interesting animals research mast cell tumor human parietal cell antibody ibuprofen half life

recently, and platinum Medicine sin pharmaceutical (http:// announced that its new generation of all-human anti-CTLA-4 antibody HBM4003 has launched the first global clinical trial (http:// fo
Noten Jianhua BTK inhibitor Obitini ICP-022 new drug listing application accepted

 Time of Update: 2020-06-07

global clinical trials phase 1 metabolism small safety glasses cyclobenzaprine drug test strip drug test

recently, it has been reported that the http:// high-selective and irreversible small molecule Bruton tyrosine kinase (BTK) inhibitor Obitini ICP-022 developed by Innocare has been accepted for the
FDA supports new treatment for Amarin's Vascepa capsule

 Time of Update: 2020-06-07

oil based gingivitis natural treatment organic fish oil clr active ingredient vitamins reduce cholesterol

, Amarin (http:// announced that the U.S FDA (http:// endocrine metabolism drug (http:// Advisory (http:// Committee (EMDAC) supports the company's development of Vascepa capsules as a new
U.S. FDA grants Kiniksa's rilonacept breakthrough therapy

 Time of Update: 2020-06-07

rapid acting insulin 1 2 ghz omega alpha beta natural drugs herpes 1 2

today, Kiniksa Pharmaceuticals (http:// announced that the U.S FDA (http:// granted its determination to treat recurrent enticatis (RP) in the il-1 signaling pathway inhibitor rilonacept Abou
FDA grants Brynering Ingeheim's breakthrough drug

 Time of Update: 2020-06-07

nintedanib tergitol 15 9 drug disease interaction small molecule inhibitors day rape drug

The u.S food and drug (http:// Administration ( FDA (http:// has granted its oral small molecule tyrosine kinase inhibitor, Oftedanib, Nidanibu, a breakthrough drug qualification (BTD), the ge
FDA approves AstraZeneca BTK inhibitor Calquence (acalabrutinib) for treatment of CLL or SLL

 Time of Update: 2020-06-07

small k562 cell line phase 4 clinical trial cell line development cell based meat

today, the u.S FDA (http:// announced approval of AstraZeneca (http:// of the BTK inhibitor Calquence (calabrutinib) as an initial or follow-up therapy for the treatment of chronic lymphatic l
FDA approves lenVIMA and KEYTRUDA for treatment of patients with advanced endometrial cancer

 Time of Update: 2020-06-07

non 24 drug plus 1 cot 2 dicyclomine weight loss chinese food dundee

today, Atva and Mershadon announced that the U.S Food and Drug (http:// Administration ( FDA (http:// ) has approved a combination of LENVIMA (Chinese) and KEYTRUDA (Chinese) for the treatment
NMPA accepts application sufaninib for new drug from Huang Chinese pharmaceutical company Surufatinib

 Time of Update: 2020-06-07

data translation mercury data science phase locked loops study cancer pancreatic cancer cells

The National medicines (http:// Regulatory Authority (NMPA ) has accepted the application for listing of the new drug (http:// for the treatment of advanced non-pancreatic neuroendocrine tumor
Skyfall And MorphoSys Announces CD38 Antibody (TJ202/MOR202) licensed by China's State Drug Administration clinical trial

 Time of Update: 2020-06-07

repatha mechanism action vedolizumab mechanism action tenofovir mechanism action rifaximin mechanism action bio company

recently, Tianyuan Biotech (Shanghai) Limited Company (http:// ("Tianyuan Bio") and Germany's MorphoSys Corporation announced that human source monoclonal CD38 antibody (TJ202/MOR202) was approve
Seattle's small molecule tyrosine kinase inhibitor tucatinib key phase 3 trial reaches primary and secondary endpoints

 Time of Update: 2020-06-07

stage 3 cte t2 breast cancer hepatocyte growth factor lab safety activity breast cancer pill

today, Seattle Genetics (http:// announced that its HER-specific oral small molecule tyrosine kinase inhibitor tucatinib, in the treatment of pre-local advanced or metastatic HER2-positive breast
FDA approves GlaxoSmithKline niraparib for treatment of terminal ovarian cancer

 Time of Update: 2020-06-07

1 2 decoder vaccines fda approved anti allergic drugs 3 types gas red 1 2

Today, the U.S FDA (http:// announced that it has approved GlaxoSmithKline (GSK) company (http:// niraparib(name Zejula) extended indications for the treatment of patients with advanced ovaria

Go to Page

Medical Research Articles

Methafluoluothantinib listing application approved for treatment of chronic adult patients with chronic myeloid leukemia

Gilead announces new clinical research data on hepatitis B functional cure new drug GS-9688

Key Phase 2 trial of DS-8201, co-developed by AstraZeneca and Phase III, reaches the main research end

Novo Nordisk Valley Gate Winter Double Insulin Injection (Novo and Jia ®) officially launched in China

Scientists develop a new drug candidate for breast cancer

The phase 3 trial of Takeda protease inhibitor Ninlaro (ixazomib) reaches the main end of the trial

NMPA approves Theiboantium drug Fycompa for treatment of seizures at age 12 and over

Three companies jointly conduct clinical trials of antibody-linked drug enfortumab vedotin and Keytruda to treat urinary skin cancer

Weishi's new drug, ® (FYCOMPA®), has been approved by China's State Drug Administration

And platinum medicine next-generation all-human anti-CTLA-4 antibody HBM4003 first patient has been successfully enrolled in the group medication

Noten Jianhua BTK inhibitor Obitini ICP-022 new drug listing application accepted

FDA supports new treatment for Amarin's Vascepa capsule

U.S. FDA grants Kiniksa's rilonacept breakthrough therapy

FDA grants Brynering Ingeheim's breakthrough drug

FDA approves AstraZeneca BTK inhibitor Calquence (acalabrutinib) for treatment of CLL or SLL

FDA approves lenVIMA and KEYTRUDA for treatment of patients with advanced endometrial cancer

NMPA accepts application sufaninib for new drug from Huang Chinese pharmaceutical company Surufatinib

Skyfall And MorphoSys Announces CD38 Antibody (TJ202/MOR202) licensed by China's State Drug Administration clinical trial

Seattle's small molecule tyrosine kinase inhibitor tucatinib key phase 3 trial reaches primary and secondary endpoints

FDA approves GlaxoSmithKline niraparib for treatment of terminal ovarian cancer